Provisional Peer-Reviewed Toxicity Values for 2-Ethylhexanol
Notice
EPA announced the release of a Provisional Peer-Reviewed Toxicity Value assessment for 2-Ethylhexanol (CASRN 104-76-7).Abstract
Provisional Peer-Reviewed Toxicity Value (PPRTV) assessments support the EPA mission to protect human health and the environment by identifying and characterizing the health hazards of chemicals of concern to the Superfund and RCRA Programs, and providing an important source of toxicity information and toxicity values for such chemicals. PPRTVs [provisional oral reference doses (p-RfDs), inhalation reference concentrations (p-RfCs), cancer risk values, and screening values] are derived after a review of the relevant scientific literature and using Agency methodologies, practices, and guidance for the development of toxicity values. Other EPA programs or external parties who choose of their own initiative to use PPRTV values are advised that Superfund resources will not be used to respond to challenges of these PPRTVs used in a context outside of the EPA Superfund Program.
Impact/Purpose
PPRTVs are toxicity values derived for use in EPAs Superfund program when a value is not available in the IRIS database. Superfund site managers use PPRTVs in decision making for waste site clean ups.
Citation
U.S. EPA. Provisional Peer-Reviewed Toxicity Values for 2-Ethylhexanol. U.S. Environmental Protection Agency, Washington, DC, EPA/690/R-19/001F, 2019.
History/Chronology
| Date | Description |
|---|---|
| April 2019 | EPA finalized and delivered the assessment to the Superfund Program. Subchronic and chronic provisional RfDs, subchronic and chronic provisional RfCs, and a provisional oral slope factor were derived and this is the first entry of this chemical into the PPRTV collection. |
| May 2019 | EPA published the final report and values on the PPRTV website. |
This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.